Current Approaches in the Treatment of Colorectal Cancer: Role of Predictive and Prognostic Biomarkers

This webcast is co-provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.

This activity is supported by educational grants from Bristol-Myers Squibb and Lilly USA, LLC.

Release date: June 26, 2014

Valid through: June 26, 2015

Target Audience:

This webcast is designed to meet the educational needs of medical oncologists and other health care professionals who diagnose, treat, and manage patients with colorectal cancer.

Program Overview:

This webcast is intended to improve care of patients with colorectal cancer by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

This program consists of 4 continuing education activites.

Module 1 — Axel Grothey, MD — 0.5 AMA PRA Category 1™ Credit Hours

Module 2 — Wells Messersmith, MD — 0.5 AMA PRA Category 1™ Credit Hours

Module 3 — Christopher Lieu, MD — 0.5 AMA PRA Category 1™ Credit Hours

Module 4 — Scott Kopetz, MD — 0.5 AMA PRA Category 1™ Credit Hours